Showing results (1891-1900 of 1,946) with videos related to
Sort By:
Pageof 195
Diabetes Technology & Therapeutics|March 9, 2022
Evaluation of Extended Infusion Set Performance in Adults with Type 1 Diabetes: Infusion Set Survival Rate and Glycemic Outcomes from a Pivotal TrialRon Brazg, Satish K Garg, Anuj Bhargava, et al.Journal of Diabetes Science and Technology|April 10, 2013
Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the ambulatory glucose profileRichard M Bergenstal, Andrew J Ahmann, Timothy Bailey, et al.Diabetes Technology & Therapeutics|March 2, 2013
Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the Ambulatory Glucose Profile (AGP)Richard M Bergenstal, Andrew J Ahmann, Timothy Bailey, et al.Cell Reports|September 27, 2025
IGF2BP3 redirects glycolytic flux to promote one-carbon metabolism and RNA methylationGunjan Sharma, Martin Gutierrez, Anthony E Jones, et al.Diabetes Technology & Therapeutics|October 25, 2021
Safety and Glycemic Outcomes During the MiniMed™ Advanced Hybrid Closed-Loop System Pivotal Trial in Adolescents and Adults with Type 1 DiabetesAnders L Carlson, Jennifer L Sherr, Dorothy I Shulman, et al.Mabs|May 11, 2021
Simlukafusp alfa (FAP-IL2v) immunocytokine is a versatile combination partner for cancer immunotherapyInja Waldhauer, Valeria Gonzalez-Nicolini, Anne Freimoser-Grundschober, et al.Diabetes Care|December 19, 2015
Risk Factors Associated With Severe Hypoglycemia in Older Adults With Type 1 DiabetesRuth S Weinstock, Stephanie N DuBose, Richard M Bergenstal, et al.JAMA Network Open|April 21, 2023
Association of Radiotherapy Duration With Clinical Outcomes in Patients With Esophageal Cancer Treated in NRG Oncology Trials: A Secondary Analysis of NRG Oncology Randomized Clinical TrialsChristopher L Hallemeier, Jennifer Moughan, Michael G Haddock, et al.Diabetes Technology & Therapeutics|June 5, 2026
Adjunctive Treatment with GLP-1 and Dual GLP-1/GIP Receptor Agonists for People with Type 1 Diabetes: Consensus Report and Practical Guidelines for Safe UseSatish K Garg, Halis K Akturk, Samita Garg, et al.Diabetes Technology & Therapeutics|August 18, 2025
Safety and Glycemic Outcomes of the MiniMed 780G System with a Disposable All-in-One SensorLaura M Nally, Jennifer L Sherr, Satish K Garg, et al.Pageof 195